Page last updated: 2024-10-16

adenine and Hyperparathyroidism, Secondary

adenine has been researched along with Hyperparathyroidism, Secondary in 8 studies

Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.

Research Excerpts

ExcerptRelevanceReference
" Here, we established a rat model with secondary hyperparathyroidism (SHPT) and bone disease induced by adenine and a high phosphorous diet and analyzed the skeletal characteristics."3.88A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet. ( Chen, Q; Liu, BC; Lv, LL; Ni, HF; Ni, LH; Song, KY; Tang, RN; Wang, B; Wang, FM; Wang, LT; Wu, M, 2018)
"After adenine dosing, significant hyperphosphatemia, hypocalcemia and secondary hyperparathyroidism (2HPT) were observed during the experimental period of 15 weeks."3.75Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. ( Fujimori, A; Fukushima, S; Itoh, H; Mizukami, K; Nara, H; Okada, M; Sanagi, M; Takakura, K; Terai, K, 2009)
"Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia."2.82Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review. ( Li, L; Ma, W; Wei, D; Ye, P; Zeng, J, 2022)
"Secondary hyperparathyroidism is characterized by increased parathyroid hormone (PTH) mRNA stability that leads to increased PTH mRNA and serum PTH levels."1.35Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. ( Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J, 2009)
"At week 9, renal failure resolved with improvement in the hyperparathyroid state."1.35Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. ( Abedat, S; Beeri, R; Ben-Dov, IZ; Danenberg, HD; Lotan, C; Meir, K; Planer, D; Shuvy, M; Sosna, J, 2008)
"Adenine-treated rats showed marked elevations of serum phosphorus, PTH and FGF23 levels associated with parathyroid hyperplasia and aortic calcification."1.33[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. ( Abe, M; Kobayashi, N; Miyata, S; Nagano, N; Wada, M; Wakita, S, 2005)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Sato, H3
Goto, M3
Nishimura, G3
Morimoto, N3
Tokushima, H3
Horii, Y3
Takahashi, N3
Zeng, J1
Ye, P1
Wei, D1
Li, L1
Ma, W1
Ni, LH1
Tang, RN1
Lv, LL1
Wu, M1
Wang, B1
Wang, FM1
Ni, HF1
Song, KY1
Wang, LT1
Chen, Q1
Liu, BC1
Nechama, M1
Ben-Dov, IZ3
Silver, J2
Naveh-Many, T2
Terai, K1
Nara, H1
Takakura, K1
Mizukami, K1
Sanagi, M1
Fukushima, S1
Fujimori, A1
Itoh, H1
Okada, M1
Galitzer, H1
Nagano, N1
Miyata, S1
Abe, M1
Wakita, S1
Kobayashi, N1
Wada, M1
Shuvy, M1
Abedat, S1
Beeri, R1
Danenberg, HD1
Planer, D1
Meir, K1
Sosna, J1
Lotan, C1

Reviews

1 review available for adenine and Hyperparathyroidism, Secondary

ArticleYear
Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adenine; Bone Diseases, Metabolic; Calcium; Humans; Hyperparathyroidism, Primary; Hyperparathyroidis

2022

Other Studies

7 other studies available for adenine and Hyperparathyroidism, Secondary

ArticleYear
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
Upacicalcet, a positive allosteric modulator of the calcium-sensing receptor, prevents vascular calcification and bone disorder in a rat adenine-induced secondary hyperparathyroidism model.
    Bone, 2023, Volume: 167

    Topics: Adenine; Animals; Bone Diseases; Calcium; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid H

2023
A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Biochemical and biophysical research communications, 2018, 04-06, Volume: 498, Issue:3

    Topics: Adenine; Animals; Bone and Bones; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Diet; Disea

2018
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
    American journal of physiology. Renal physiology, 2009, Volume: 296, Issue:4

    Topics: 3' Untranslated Regions; Adenine; Aniline Compounds; Animals; Calcium; Chronic Disease; Disease Mode

2009
Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
    British journal of pharmacology, 2009, Volume: 156, Issue:8

    Topics: Adenine; Animals; Aortic Diseases; Biomarkers; Blood Urea Nitrogen; Calcinosis; Calcium; Calcium Car

2009
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
    Kidney international, 2010, Volume: 77, Issue:3

    Topics: Adenine; Animals; Chronic Disease; Down-Regulation; Fibroblast Growth Factor-23; Fibroblast Growth F

2010
[Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Clinical calcium, 2005, Volume: 15 Suppl 1

    Topics: Adenine; Animals; Aortic Diseases; Calcinosis; Calcium; Disease Models, Animal; Drug Administration

2005
Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.
    Cardiovascular research, 2008, Aug-01, Volume: 79, Issue:3

    Topics: Adenine; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Aortic Valve; Blotting, W

2008